Bruns A D, Zieske L A, Jacobs A J
Department of Surgery, Tripler Army Medical Center, Honolulu, HI 96859-5000.
Otolaryngol Head Neck Surg. 1994 Dec;111(6):722-6. doi: 10.1016/s0194-5998(94)70558-5.
Cocaine is considered a superb anesthetic for many otolaryngologic procedures and has been shown to be positive in the urine of patients for up to 72 hours after surgery with a standard radioimmunoassay test. The standard cutoff for drug screening of benzoylecgonine, the main urine metabolite of cocaine, has been 300 ng/ml. However, the new threshold value in many laboratories is now 150 ng/ml. In review of the literature, no study has been performed that quantitates the actual level of the urine cocaine metabolite after a routine otolaryngologic procedure in both physicians and their patients with the gold standard for urine testing, gas chromatography. This study documents the quantitative level of the urine cocaine metabolite in patients and reveals that there are metabolite levels present in physicians during a single exposure, although they are below the current cutoff level that will be picked up on current screening assays. Evidence has also been presented demonstrating a cumulative effect on the benzoylecgonine levels in physicians who clinically use cocaine anesthesia more frequently; these levels can be above the cutoff level on current screening assays.
可卡因被认为是许多耳鼻喉科手术的优质麻醉剂,并且通过标准放射免疫分析测试表明,术后长达72小时患者尿液中可卡因仍呈阳性。可卡因主要尿液代谢物苯甲酰爱康宁的药物筛查标准临界值一直是300纳克/毫升。然而,现在许多实验室的新临界值是150纳克/毫升。在文献综述中,尚未有研究采用尿液检测的金标准——气相色谱法,对医生及其患者在常规耳鼻喉科手术后尿液中可卡因代谢物的实际水平进行定量分析。本研究记录了患者尿液中可卡因代谢物的定量水平,并揭示出单次接触后医生体内也存在代谢物水平,尽管这些水平低于当前筛查检测所能检测到的当前临界值。也有证据表明,对于更频繁临床使用可卡因麻醉的医生,苯甲酰爱康宁水平会产生累积效应;这些水平可能高于当前筛查检测的临界值。